5-Benzyloxytryptamine (5-BT), is a tryptamine derivative which acts as an agonist at the 5-HT1D, 5-HT2 and 5-HT6 serotonin receptors,[1][2][3][4] and an antagonist of TRPM8.[5]
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.040.007 |
Chemical and physical data | |
Formula | C17H18N2O |
Molar mass | 266.344 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Legality
edit5-Benzyloxytryptamine is illegal in Singapore.[6]
See also
editReferences
edit- ^ Lyon RA, Titeler M, Seggel MR, Glennon RA (January 1988). "Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens". European Journal of Pharmacology. 145 (3): 291–297. doi:10.1016/0014-2999(88)90432-3. PMID 3350047.
- ^ Peroutka SJ, McCarthy BG, Guan XM (1991). "5-benzyloxytryptamine: a relatively selective 5-hydroxytryptamine 1D/1B agent". Life Sciences. 49 (6): 409–418. doi:10.1016/0024-3205(91)90582-V. PMID 1650872.
- ^ Cohen ML, Schenck K, Nelson D, Robertson DW (January 1992). "Sumatriptan and 5-benzyloxytryptamine: contractility of two 5-HT1D receptor ligands in canine saphenous veins". European Journal of Pharmacology. 211 (1): 43–46. doi:10.1016/0014-2999(92)90260-B. PMID 1319907.
- ^ Boess FG, Monsma FJ, Carolo C, Meyer V, Rudler A, Zwingelstein C, Sleight AJ (1997). "Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells". Neuropharmacology. 36 (4–5): 713–720. doi:10.1016/S0028-3908(97)00019-1. PMID 9225298. S2CID 41813873.
- ^ DeFalco J, Steiger D, Dourado M, Emerling D, Duncton MA (December 2010). "5-benzyloxytryptamine as an antagonist of TRPM8". Bioorganic & Medicinal Chemistry Letters. 20 (23): 7076–7079. doi:10.1016/j.bmcl.2010.09.099. PMID 20965726.
- ^ "Misuse of Drugs Act - Singapore Statutes Online". sso.agc.gov.sg.